Antimicrobial peptides: primeval molecules or future drugs?
about
The mucosal immune system: From dentistry to vaccine developmentReactive oxygen species, apoptosis, antimicrobial peptides and human inflammatory diseasesPeptidomimetics as a new generation of antimicrobial agents: current progresspH Dependent Antimicrobial Peptides and Proteins, Their Mechanisms of Action and Potential as Therapeutic AgentsNeutrophils: Between host defence, immune modulation, and tissue injuryThe Bacillus subtilis cannibalism toxin SDP collapses the proton motive force and induces autolysisIn silico approach for predicting toxicity of peptides and proteinsAn antimicrobial peptidomimetic induces Mucorales cell death through mitochondria-mediated apoptosisL-Rhamnosylation of Listeria monocytogenes Wall Teichoic Acids Promotes Resistance to Antimicrobial Peptides by Delaying Interaction with the MembraneInvolvement of β-defensin 130 (DEFB130) in the macrophage microbicidal mechanisms for killing Plasmodium falciparumDe novo design and synthesis of ultra-short peptidomimetic antibiotics having dual antimicrobial and anti-inflammatory activities.Antimicrobial peptides extend lifespan in Drosophila.Antimicrobial peptides secreted by equine mesenchymal stromal cells inhibit the growth of bacteria commonly found in skin woundsAntimicrobial peptides: new drugs for bad bugs?Innate immune regulation by STAT-mediated transcriptional mechanisms.Symbiotic plant peptides eliminate Candida albicans both in vitro and in an epithelial infection model and inhibit the proliferation of immortalized human cells.Inactivation of the budded virus of Autographa californica M nucleopolyhedrovirus by gloverin.Clinical use of colistin induces cross-resistance to host antimicrobials in Acinetobacter baumannii.Antimicrobial peptide trichokonin VI-induced alterations in the morphological and nanomechanical properties of Bacillus subtilis.Structure-activity relationships of the antimicrobial peptide arasin 1 - and mode of action studies of the N-terminal, proline-rich regionCecropin P1 inhibits porcine reproductive and respiratory syndrome virus by blocking attachment.Importance of Tryptophan in Transforming an Amphipathic Peptide into a Pseudomonas aeruginosa-Targeted Antimicrobial Peptide.Identification of a novel antimicrobial peptide from human hepatitis B virus core protein arginine-rich domain (ARD)A simple assay to screen antimicrobial compounds potentiating the activity of current antibiotics.An innovative biologic recycling process of leukoreduction filters to produce active human antimicrobial peptides.Streptococcus mutans, Candida albicans, and the human mouth: a sticky situation.A novel chemosynthetic peptide with β-sheet motif efficiently kills Klebsiella pneumoniae in a mouse model.Probiotics, nuclear receptor signaling, and anti-inflammatory pathways.Production of cecropin A antimicrobial peptide in rice seed endosperm.Discovery of modulators of HIV-1 infection from the human peptidome.Exploring the pharmacological potential of promiscuous host-defense peptides: from natural screenings to biotechnological applications.The application of antimicrobial peptides as growth and health promoters for swine.Effects of neutrophils peptide-1 transgenic Chlorella ellipsoidea on the gut microbiota of male Sprague-Dawley rats, as revealed by high-throughput 16S rRNA sequencing.Natural Anti-Infective Pulmonary Proteins: In Vivo Cooperative Action of Surfactant Protein SP-A and the Lung Antimicrobial Peptide SP-BNEfficacy of the antimicrobial peptide TP4 against Helicobacter pylori infection: in vitro membrane perturbation via micellization and in vivo suppression of host immune responses in a mouse modelCandida albicans Pathogenesis: Fitting within the Host-Microbe Damage Response Framework.Activity of tick antimicrobial peptide from Ixodes persulcatus (persulcatusin) against cell membranes of drug-resistant Staphylococcus aureus.Bactericidal, quorum quenching and anti-biofilm nanofactories: a new niche for nanotechnologists.In Vivo Effects of Pichia Pastoris-Expressed Antimicrobial Peptide Hepcidin on the Community Composition and Metabolism Gut Microbiota of Rats.In Vitro Activity of the Novel Antimicrobial Peptide Dendrimer G3KL against Multidrug-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
P2860
Q26783887-40D6470D-294F-4512-979D-0F496733A51AQ26823282-A9458B74-B5BC-4D27-81B9-D6224302DD4EQ27026959-1C312FB2-3403-4D5E-A78A-BD9D47182A79Q28070241-9AEC07CD-E7BC-4BEB-A640-3D93F803B074Q28087227-38FAA5E8-B185-4D12-B0EC-C8A1DBD1AA12Q28489015-1253C8E9-2FDE-4E87-9AA6-A0963833014DQ28533436-FC7BCB61-CBA5-40C9-A886-CDFA93F6E83DQ28534020-7EDE571C-9B44-4054-B812-38E898B0480FQ28547427-B1562AAA-A280-49BD-8B92-BC7F1A16B71DQ30179429-7772C4A0-2420-4C5C-9418-56CCAF1F7AB7Q31145703-D53626CD-87D8-4B3F-8474-9FCC304DEBCDQ33698878-1010093D-518D-46AD-94DB-8283900BFA7DQ33869297-73D32ACB-71CA-4E0D-9D00-BFEB4362E331Q33944903-48BB484B-67E1-43D6-966D-FB4DDC606E5EQ34055968-7F3E9E96-265E-444C-A009-01D29A8B6885Q34177095-31B51AF2-01D8-4320-83C9-57520DC516A2Q34188708-F978B46D-87A7-45AC-B971-2C12503C08A9Q34346016-27644DC9-88BB-4760-9EEF-8D50A5B04FE8Q34438461-37941537-C661-472B-AF2A-DFECE1F8D2D9Q34551319-0D4A73F0-48FF-41F9-AD48-82E76C5B8362Q34568428-E5B0933F-17E0-45B3-A756-BC71722F6BDAQ34672675-62A61E62-908B-4BA2-9FC9-17C7366E67D8Q34778507-A038D657-F1C0-4673-BBA2-CD181D810DB7Q34830742-36D412EA-68D2-4322-9422-82BBABEDC9FEQ35015443-36849F86-D91E-4F07-9AD2-F354EE7C7559Q35022288-C0C0C8DE-DF43-4D21-A2FA-3F00A24B466DQ35087989-2F8D11DB-7824-4715-A699-8F1A6D6B6E49Q35131051-FA3E33FD-11D4-44B2-A298-09F259D49D28Q35154732-B875B921-890C-4A4A-922D-ECAAE86495E3Q35222585-84566559-221E-4DE8-B597-6C3A3337BDC8Q35567364-28BFFD5D-B1CA-4A95-98E7-BE97918EB0E6Q35652933-81E180A9-4B58-4EA1-8C8A-7BBC21A1C359Q35923005-FA5982CB-DB5A-431B-A67E-E38257570109Q35931668-EFFEFC1C-5076-464F-804E-828E817275C7Q35955162-4CB60886-F8EB-4902-81FC-A390FA9D4568Q36080619-A6E0814C-E183-49C1-8FAB-C6E23142DB91Q36105396-C3C5DFB0-4C7B-4EDA-8F94-6C4EB53536C4Q36147786-5266CFC4-5E3D-4E0E-A072-9A5E012F1DDBQ36170975-787DD406-5A8D-40B3-92FC-4C71AE7DB119Q36290577-56C80149-C3F8-4E9C-A25A-56E7AF825A31
P2860
Antimicrobial peptides: primeval molecules or future drugs?
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Antimicrobial peptides: primeval molecules or future drugs?
@ast
Antimicrobial peptides: primeval molecules or future drugs?
@en
type
label
Antimicrobial peptides: primeval molecules or future drugs?
@ast
Antimicrobial peptides: primeval molecules or future drugs?
@en
prefLabel
Antimicrobial peptides: primeval molecules or future drugs?
@ast
Antimicrobial peptides: primeval molecules or future drugs?
@en
P2093
P2860
P1433
P1476
Antimicrobial peptides: primeval molecules or future drugs?
@en
P2093
Brian M Peters
Mark E Shirtliff
Mary Ann Jabra-Rizk
P2860
P304
P356
10.1371/JOURNAL.PPAT.1001067
P577
2010-10-28T00:00:00Z